In February 2009, the patient was rehospitalized because of a second recurrence of massive hemoptysis. Angiography revealed a significantly dilated network of pathologic vessels supplied by the right bronchial artery (Fig 1A). Neither fistulae nor branches going toward the spinal canal were found. A Renegade 2.8F microcatheter (Boston Scientific; Natick, Massachusetts) was inserted into the right bronchial artery and one vial of 500 to 700 μm Embosphere (BioSphere Medical; Rockland, Massachusetts) particles were injected to occlude the artery. Hemoptysis stopped after this successful intervention, which was followed by mild postembolization syndrome characterized by pleuritic chest pain, pleural fluid, fever, and leukocytosis. One month later, the patient required a reintervention because of hemoptysis recurrence. Pathologic collateral vessels of the right side were embolized (Figs 1B, 1C). During the next 8 months, the patient improved to WHO FC II. In December 2009, another episode of massive hemoptysis occurred. A control CT scan and arteriography, followed by BAE of the bleeding vessels in the right lung, were performed. The intervention was well tolerated; however, effective bleeding control did not prevent the patient from experiencing an exacerbation of respiratory insufficiency in the following hours. The patient presented with an aggravation of dyspnea, a gradual fall in BP (from 100/60 mm Hg originally to 50/40 mm Hg), tachycardia, and a decrease in oxygen saturation (minimally to 82%). Despite high-flow oxygen delivery through a face mask, followed by mechanical ventilation, the patient died of electromechanical dissociation.